List of Tables
Table 1. Global Cyclophosphamide Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cyclophosphamide Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cyclophosphamide Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cyclophosphamide Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Cyclophosphamide Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cyclophosphamide Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cyclophosphamide Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cyclophosphamide Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cyclophosphamide Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cyclophosphamide Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cyclophosphamide Injection, Product Type & Application
Table 12. Global Key Manufacturers of Cyclophosphamide Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cyclophosphamide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclophosphamide Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cyclophosphamide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cyclophosphamide Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Cyclophosphamide Injection Sales Market Share by Region (2020-2025)
Table 19. Global Cyclophosphamide Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Cyclophosphamide Injection Sales Market Share by Region (2026-2031)
Table 21. Global Cyclophosphamide Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cyclophosphamide Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Cyclophosphamide Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cyclophosphamide Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Cyclophosphamide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cyclophosphamide Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Cyclophosphamide Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Cyclophosphamide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cyclophosphamide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cyclophosphamide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cyclophosphamide Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Cyclophosphamide Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Cyclophosphamide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cyclophosphamide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cyclophosphamide Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cyclophosphamide Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Cyclophosphamide Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Cyclophosphamide Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cyclophosphamide Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cyclophosphamide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cyclophosphamide Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Cyclophosphamide Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Cyclophosphamide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cyclophosphamide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cyclophosphamide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cyclophosphamide Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Cyclophosphamide Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Cyclophosphamide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cyclophosphamide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cyclophosphamide Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Cyclophosphamide Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Cyclophosphamide Injection Sales Market Share by Type (2020-2025)
Table 53. Global Cyclophosphamide Injection Sales Market Share by Type (2026-2031)
Table 54. Global Cyclophosphamide Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cyclophosphamide Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cyclophosphamide Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Cyclophosphamide Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Cyclophosphamide Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Cyclophosphamide Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Cyclophosphamide Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Cyclophosphamide Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Cyclophosphamide Injection Sales Market Share by Application (2020-2025)
Table 63. Global Cyclophosphamide Injection Sales Market Share by Application (2026-2031)
Table 64. Global Cyclophosphamide Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cyclophosphamide Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cyclophosphamide Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Cyclophosphamide Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Cyclophosphamide Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Cyclophosphamide Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Baxter Cyclophosphamide Injection Product
Table 74. Baxter Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Cyclophosphamide Injection Product
Table 79. Novartis Recent Developments/Updates
Table 80. Amneal Pharmaceuticals Company Information
Table 81. Amneal Pharmaceuticals Description and Business Overview
Table 82. Amneal Pharmaceuticals Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Amneal Pharmaceuticals Cyclophosphamide Injection Product
Table 84. Amneal Pharmaceuticals Recent Developments/Updates
Table 85. Aurobindo Pharma Company Information
Table 86. Aurobindo Pharma Description and Business Overview
Table 87. Aurobindo Pharma Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Aurobindo Pharma Cyclophosphamide Injection Product
Table 89. Aurobindo Pharma Recent Developments/Updates
Table 90. Zydus Cadila Company Information
Table 91. Zydus Cadila Description and Business Overview
Table 92. Zydus Cadila Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Zydus Cadila Cyclophosphamide Injection Product
Table 94. Zydus Cadila Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer Cyclophosphamide Injection Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Athenex Company Information
Table 101. Athenex Description and Business Overview
Table 102. Athenex Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Athenex Cyclophosphamide Injection Product
Table 104. Athenex Recent Developments/Updates
Table 105. GLS Pharma Company Information
Table 106. GLS Pharma Description and Business Overview
Table 107. GLS Pharma Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. GLS Pharma Cyclophosphamide Injection Product
Table 109. GLS Pharma Recent Developments/Updates
Table 110. NorthStar Rx LLC Company Information
Table 111. NorthStar Rx LLC Description and Business Overview
Table 112. NorthStar Rx LLC Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. NorthStar Rx LLC Cyclophosphamide Injection Product
Table 114. NorthStar Rx LLC Recent Developments/Updates
Table 115. Jiangsu Hengrui Medicine Company Information
Table 116. Jiangsu Hengrui Medicine Description and Business Overview
Table 117. Jiangsu Hengrui Medicine Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Jiangsu Hengrui Medicine Cyclophosphamide Injection Product
Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 120. Getwell Oncology Company Information
Table 121. Getwell Oncology Description and Business Overview
Table 122. Getwell Oncology Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Getwell Oncology Cyclophosphamide Injection Product
Table 124. Getwell Oncology Recent Developments/Updates
Table 125. Ingenus Company Information
Table 126. Ingenus Description and Business Overview
Table 127. Ingenus Cyclophosphamide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Ingenus Cyclophosphamide Injection Product
Table 129. Ingenus Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Cyclophosphamide Injection Distributors List
Table 133. Cyclophosphamide Injection Customers List
Table 134. Cyclophosphamide Injection Market Trends
Table 135. Cyclophosphamide Injection Market Drivers
Table 136. Cyclophosphamide Injection Market Challenges
Table 137. Cyclophosphamide Injection Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cyclophosphamide Injection
Figure 2. Global Cyclophosphamide Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cyclophosphamide Injection Market Share by Type: 2024 & 2031
Figure 4. High-Dose Product Picture
Figure 5. Low-Dose Product Picture
Figure 6. Global Cyclophosphamide Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Cyclophosphamide Injection Market Share by Application: 2024 & 2031
Figure 8. Cancer
Figure 9. Autoimmune Diseases
Figure 10. AL Amyloidosis
Figure 11. Others
Figure 12. Global Cyclophosphamide Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cyclophosphamide Injection Market Size (2020-2031) & (US$ Million)
Figure 14. Global Cyclophosphamide Injection Sales (2020-2031) & (K Units)
Figure 15. Global Cyclophosphamide Injection Average Price (US$/Unit) & (2020-2031)
Figure 16. Cyclophosphamide Injection Report Years Considered
Figure 17. Cyclophosphamide Injection Sales Share by Manufacturers in 2024
Figure 18. Global Cyclophosphamide Injection Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Cyclophosphamide Injection Players: Market Share by Revenue in Cyclophosphamide Injection in 2024
Figure 20. Cyclophosphamide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Cyclophosphamide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Cyclophosphamide Injection Sales Market Share by Country (2020-2031)
Figure 23. North America Cyclophosphamide Injection Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Cyclophosphamide Injection Sales Market Share by Country (2020-2031)
Figure 27. Europe Cyclophosphamide Injection Revenue Market Share by Country (2020-2031)
Figure 28. Germany Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Cyclophosphamide Injection Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Cyclophosphamide Injection Revenue Market Share by Region (2020-2031)
Figure 35. China Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Cyclophosphamide Injection Sales Market Share by Country (2020-2031)
Figure 46. Latin America Cyclophosphamide Injection Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Cyclophosphamide Injection Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Cyclophosphamide Injection Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Cyclophosphamide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Cyclophosphamide Injection by Type (2020-2031)
Figure 56. Global Revenue Market Share of Cyclophosphamide Injection by Type (2020-2031)
Figure 57. Global Cyclophosphamide Injection Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Cyclophosphamide Injection by Application (2020-2031)
Figure 59. Global Revenue Market Share of Cyclophosphamide Injection by Application (2020-2031)
Figure 60. Global Cyclophosphamide Injection Price (US$/Unit) by Application (2020-2031)
Figure 61. Cyclophosphamide Injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
